The document summarizes research on the IC-8TM small-aperture intraocular lens. Optical modeling shows it extends the depth of focus compared to monofocal and bifocal lenses. Clinical data from patients found it provided a broad range of clear vision from near to far, with minimal visual symptoms. The IC-8TM lens can be implanted using standard cataract surgery techniques and allows for posterior segment assessments and procedures.
SPOTLIGHT ON THE PREMIUM CHANNEL – AcuFocusHealthegy
Presentation from OIS@ASCRS 2016
Nick Tarantino, OD, Chief Global Clinical & Regulatory Affairs Officer
Video Presentation:
https://www.youtube.com/watch?v=Nc4T9u62rBQ&list=PL1dmdBNnPTZJBhQxPOp0vdNg3s3wtN2yw&index=34
Richard L. Lindstrom, MD's "Thoughts on Corneal and Lens based Refractive Surgery to Enhance Near Vision in the USA: 2015" presentation from OIS@ASCRS 2015
SPOTLIGHT ON THE PREMIUM CHANNEL - Abbott Medical OpticsHealthegy
Presentation from OIS@ASCRS 2016
Leonard Borrmann, Divisional VP, R&D
Video Presentation:
https://www.youtube.com/watch?v=02VOUB17Xp8&list=PL1dmdBNnPTZJBhQxPOp0vdNg3s3wtN2yw&index=38
DIAGNOSTICS-IMPACT ON THE PREMIUM CHANNEL - AlconHealthegy
Presentation from OIS@ASCRS 2016
Seba Leoni, VP & Global Head, Surgical Suite
Video Presentation:
https://www.youtube.com/watch?v=hidfQJsrV4o&list=PL1dmdBNnPTZJBhQxPOp0vdNg3s3wtN2yw&index=24
SPOTLIGHT ON THE PREMIUM CHANNEL – AcuFocusHealthegy
Presentation from OIS@ASCRS 2016
Nick Tarantino, OD, Chief Global Clinical & Regulatory Affairs Officer
Video Presentation:
https://www.youtube.com/watch?v=Nc4T9u62rBQ&list=PL1dmdBNnPTZJBhQxPOp0vdNg3s3wtN2yw&index=34
Richard L. Lindstrom, MD's "Thoughts on Corneal and Lens based Refractive Surgery to Enhance Near Vision in the USA: 2015" presentation from OIS@ASCRS 2015
SPOTLIGHT ON THE PREMIUM CHANNEL - Abbott Medical OpticsHealthegy
Presentation from OIS@ASCRS 2016
Leonard Borrmann, Divisional VP, R&D
Video Presentation:
https://www.youtube.com/watch?v=02VOUB17Xp8&list=PL1dmdBNnPTZJBhQxPOp0vdNg3s3wtN2yw&index=38
DIAGNOSTICS-IMPACT ON THE PREMIUM CHANNEL - AlconHealthegy
Presentation from OIS@ASCRS 2016
Seba Leoni, VP & Global Head, Surgical Suite
Video Presentation:
https://www.youtube.com/watch?v=hidfQJsrV4o&list=PL1dmdBNnPTZJBhQxPOp0vdNg3s3wtN2yw&index=24
Presentation from OIS@ASCRS 2016
Co-Moderators:
Gilbert H. Kliman, MD, Managing Director – InterWest Partners
Stephen Slade, MD
Company Presentations
Equinox | John Berdahl, MD, Founder & CEO
Presbyopia Therapies | Jim McCollum, Co-Founder
Stroma Medical | Doug Daniels, CEO
Eyenovia | Curt LaBelle, MD, Director
Wicab | Robert Beckman, President & COO
Presentation from OIS@ASCRS 2016
Rajesh K. Rajpal, MD, Chief Medical Officer
Video Presentation:
https://www.youtube.com/watch?v=Wbq-D5kwMUk&list=PL1dmdBNnPTZJBhQxPOp0vdNg3s3wtN2yw&index=39
Presentation from OIS@ASCRS 2016
Mike Judy, CEO
Video of Presentation:
https://www.youtube.com/watch?v=G5ZfnPKlBSY&list=PL1dmdBNnPTZJBhQxPOp0vdNg3s3wtN2yw&index=13
Presentation from OIS@ASCRS 2016
Mark Packer, MD, Chief Medical Officer
Video Presentation:
https://www.youtube.com/watch?v=CWwqmEDJOhM&index=20&list=PL1dmdBNnPTZJBhQxPOp0vdNg3s3wtN2yw
Presentation from OIS@ASCRS 2016
John Hendrick, President & CEO
Video Presentation:
https://www.youtube.com/watch?v=c2J1g7HYuek&index=24&list=PL1dmdBNnPTZJBhQxPOp0vdNg3s3wtN2yw
Presentation from OIS@ASCRS 2016
Dave Van Meter, President & CEO
Video Presentations:
https://www.youtube.com/watch?v=aisY-FTnTyM&index=26&list=PL1dmdBNnPTZJBhQxPOp0vdNg3s3wtN2yw
Presentation from OIS@ASCRS 2016
Co-Moderators:
Gilbert H. Kliman, MD, Managing Director – InterWest Partners
Stephen Slade, MD
Company Presentations
Equinox | John Berdahl, MD, Founder & CEO
Presbyopia Therapies | Jim McCollum, Co-Founder
Stroma Medical | Doug Daniels, CEO
Eyenovia | Curt LaBelle, MD, Director
Wicab | Robert Beckman, President & COO
Presentation from OIS@ASCRS 2016
Rajesh K. Rajpal, MD, Chief Medical Officer
Video Presentation:
https://www.youtube.com/watch?v=Wbq-D5kwMUk&list=PL1dmdBNnPTZJBhQxPOp0vdNg3s3wtN2yw&index=39
Presentation from OIS@ASCRS 2016
Mike Judy, CEO
Video of Presentation:
https://www.youtube.com/watch?v=G5ZfnPKlBSY&list=PL1dmdBNnPTZJBhQxPOp0vdNg3s3wtN2yw&index=13
Presentation from OIS@ASCRS 2016
Mark Packer, MD, Chief Medical Officer
Video Presentation:
https://www.youtube.com/watch?v=CWwqmEDJOhM&index=20&list=PL1dmdBNnPTZJBhQxPOp0vdNg3s3wtN2yw
Presentation from OIS@ASCRS 2016
John Hendrick, President & CEO
Video Presentation:
https://www.youtube.com/watch?v=c2J1g7HYuek&index=24&list=PL1dmdBNnPTZJBhQxPOp0vdNg3s3wtN2yw
Presentation from OIS@ASCRS 2016
Dave Van Meter, President & CEO
Video Presentations:
https://www.youtube.com/watch?v=aisY-FTnTyM&index=26&list=PL1dmdBNnPTZJBhQxPOp0vdNg3s3wtN2yw
NW2012 Intraocular Lens Design and Effects on VisionNawat Watanachai
some information about intraocular lens materials, designs; and their effect on surgery and visual function.
I'm sorry that i one i previously uploaded was the wrong file.
What's New In Glaucoma Surgery [OD CE 2 credit hours] - PPT Slides and VideosDr David Richardson
What's New In Glaucoma Surgery Presentation. A Continuing Education course for Optometrists presented by Patient-Focused Ophthalmologist, Dr. David Richardson.
At the end of the presentation audience participants became familiar with the main benefits and risks of currently available glaucoma treatments as well as had awareness of the most promising potential future surgical glaucoma treatments.
This OD CE Course was held at Green Street Tavern, Pasadena, CA last May 20, 2015.
=========================
[Glaucoma Surgeon, California] Dr. David Richardson is a board certified Ophthalmologist and Eye Surgeon in California specializing in the treatment of Cataract and Glaucoma. He is the Medical Director of San Marino Eye (Vision Center), located in San Marino, California. He’s the former Chief of Surgery and now Vice Chief of Staff at San Gabriel Valley Medical Center. Dr. Richardson has performed thousands of advanced cataract and Canaloplasty glaucoma procedures with excellent results.
More information about Dr. Richardson: http://David-Richardson-MD.com
New Glaucoma Treatments is a GLAUCOMA HealthHub maintained by David Richardson, M.D. It’s primary purpose is to provide valuable information to glaucoma patients and their caregivers worldwide about the latest developments and treatments for glaucoma, while providing answers to commonly asked questions about glaucoma, care and treatment options.
More information about new glaucoma treatments here: http://new-glaucoma-treatments.com
National Ocular Biometry Course (NOBC) 2015 An echoslide presentation Anis Suzanna Mohamad
This powerpoint presentation is basically about ocular biometry. Echo presentation is one of the method to deliver infomation that obtain from the course we attend to other staff in our Ophthalmology Department.
The Commonwealth Fund - Putting the Patient at the Center of the Digital Univ...Healthegy
Keynote Address - Presentation by Commonwealth Fund at Digital Healthcare Innovation Summit 2016
Participant:
David Blumenthal, MD, MPP, President & CEO – Commonwealth Fund
Introduced By:
Robert Mittendorff, MD, MBA, Partner – Norwest Venture Partners
Powered by:
Healthegy
For more healthcare innovation
Visit us at Healthegy.com
StartUp Health - Private Market Perspectives - Digital Healthcare Innovation ...Healthegy
Presentation by StartUp Health at Digital Healthcare Innovation Summit 2016.
Participant:
Katya Hancock, Director of Strategic Partnerships – StartUp Health
Introduced By:
Tom Salemi, Content Director – Healthegy
Powered by:
Healthegy
For more healthcare innovation
Visit us at Healthegy.com
Masters of the Industry at OIS@AAO 2016.
Moderated By:
Jim Mazzo, Global President Ophthalmic Devices - Carl Zeiss Meditec
Participants:
Flemming Ornskov, MD, CEO - Shire
Mike Ball, CEO - Alcon
Ashley McEvoy, Company Group Chairman - Johnson & Johnson Vision Care
William J. Link, PhD, Managing Director - Versant Ventures
Ludwin Monz, PhD, President & CEO - Carl Zeiss Meditec
William Meury, Chief Commercial Officer - Allergan
Powered by:
Healthegy
For more ophthalmology innovation
Visit us at www.ois.net
Anterior Segment Company Showcase - EnvisiaHealthegy
Anterior Segment Company Showcase - Envisia at OIS@AAO 2016.
Presenter:
Benjamin Yerxa, PhD, President
Powered by:
Healthegy
For more ophthalmology innovation
Visit us at www.ois.net
Public Device & Biopharma Ophthalmology Company Showcase - QLTHealthegy
Public Device & Biopharma Ophthalmology Company Showcase - QLT at OIS@AAO 2016.
Presenter:
David Saperstein, MD, Chief Medical Advisor
Powered by:
Healthegy
For more ophthalmology innovation
Visit us at www.ois.net
Public Device & Biopharma Ophthalmology Company Showcase - pSividaHealthegy
Public Device & Biopharma Ophthalmology Company Showcase - pSivida at OIS@AAO 2016.
Presenter:
Nancy Lurker, President & CEO
Powered by:
Healthegy
For more ophthalmology innovation
Visit us at www.ois.net
Public Device & Biopharma Ophthalmology Company Showcase - OmerosHealthegy
Public Device & Biopharma Ophthalmology Company Showcase - Omeros at OIS@AAO 2016.
Presenter:
Leonard M. Blum, Chief Business & Commercial Officer
Powered by:
Healthegy
For more ophthalmology innovation
Visit us at www.ois.net
Public Device & Biopharma Ophthalmology Company Showcase - Inotek Pharmaceuti...Healthegy
Public Device & Biopharma Ophthalmology Company Showcase - Inotek Pharmaceuticals at OIS@AAO 2016.
Presenter:
David Southwell, President & CEO
Powered by:
Healthegy
For more ophthalmology innovation
Visit us at www.ois.net
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfEnterprise Wired
From navigating policy options to staying informed about industry trends, this comprehensive guide explores everything you need to know about the health insurance market.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
2. Depth of Focus Comparison
Optical Modeling, 3.0 mm Pupil
IC-8™Small Aperture IOL Extended Depth of Focus (TC -0.75D)
Standard Mono-focal
0.0 D -0.5 D -1.0 D -1.5 D -2.0 D -2.5 D
20/50
20/40
20/30
20/20
20/10
20/50
20/40
20/30
20/20
20/10
20/50
20/40
20/30
20/20
20/10
2
Diffractive Bi-focal
0.0 D -0.5 D -1.0 D -1.5 D
(66 cm)
-2.0 D
(50 cm)
-2.5 D
(40 cm)
0.0 D -0.5 D -1.0 D -1.5 D -2.0 D -2.5 D
3. IC-8™ IOL Extends Depth of Focus
• Defocus curve results from IC-8 IOL patients demonstrate broad range of
vision across near, intermediate and far distances versus a monofocal IOL
• Mean post-op MRSE at their last follow-up was -0.14 D +/- 0.52
Data courtesy of Robert Ang, MD
-0.20
-0.10
0.00
0.10
0.20
0.30
0.40
0.50
0.60
0.70
0.80
0.90
1.00
1.10
Acuity(LogMAR)
Defocus Lens Power
Simulated Monofocal IOL Ang 6M (n=8)
Far Near
20/25
20/40
4. Forgiving Design
• Combining with a small amount of myopia further extends depth of
focus
• If refractive target is missed, patient still achieve good range from
near
Data courtesy of Robert Ang, MD
-0.20
-0.10
0.00
0.10
0.20
0.30
0.40
0.50
0.60
0.70
0.80
0.90
1.00
1.10
Acuity(LogMAR)
Defocus Lens Power
Simulated Monofocal IOL Ang 6M (n=8)
Far Near
20/25
20/40
5. Near Visual Acuity
Uncorrected and Target Corrected
• Mean achieved UCNVA in the IC-8™ eye is J2, with refractive target
correction to -0.75 D mean improves to J1
• 89% of eyes achieved J1 or better TCNVA
22%
89%
100% 100%
89%
100% 100% 100%
0%
20%
40%
60%
80%
100%
>=J1 >=J2 >=J3 >=J5
Uncorrected & Target Corrected
Near Visual Acuity
UCNVA IE TCNVA IE
Data courtesy of Robert Ang, MD (n=9)
TCNVA: Visual acuity tested at -0.75 DS
6. Intermediate and Distance Acuity
Uncorrected and Target Corrected
• Mean achieved UCIVA, TCIVA, UCDVA and TCDVA in the IC-8™ eye is
20/20
• 100% of patients achieved 20/25 TCIVA and TCDVA
44%
67%
100% 100%
78%
100% 100% 100%
0%
20%
40%
60%
80%
100%
>=20/20 >=20/25 >=20/32 >=20/40
Uncorrected & Target Corrected
Intermediate Visual Acuity
UCIVA IE TCIVA IE
Data courtesy of Robert Ang, MD (n=9)
TCIVA and TCDVA: Visual acuity tested at -0.75 DS
67%
78%
100% 100%
56%
100% 100% 100%
0%
20%
40%
60%
80%
100%
>=20/20 >=20/25 >=20/32 >=20/40
Uncorrected & Target Corrected
Distance Visual Acuity
UCDVA IE TCDVA IE
7. Reported Visual Symptoms Remain Low
• Comparison between eyes shows similar scores for
all symptoms ratings
Data courtesy of Robert Ang, MD (n=9)
QUESTIONAIRE:
Patients were asked to
rate the presence of
visual symptoms on a
scale of 0 to 7
(0=None, 7=Severe)
None
Severe
0
1
2
3
4
5
6
7
Subjective Symptoms
IC-8 Eye (IE) vs. Fellow Eye (FE)
Month 12 FE
Month 12 IE
8. No Surgical Adaptation Needed
• Personal cataract removal technique
acceptable
– Choice of manual or femtosecond
laser-created incisions, capsulotomy
and lens fragmentation
• In the bag lens placement same as any
standard IOL:
– Haptics at 6 and 12 o’clock
• To date no centration issues experienced
with any version of the lens
9. Ocular Assessment & Posterior Segment
Procedures Possible
• Imaging through the IOL mask central
aperture is possible minimal differences
noted between IC-8 IOL and fellow monofocal
IOL implanted eyes1 (Visual field, fundus
photography, and retinal OCT)
• Technicians reported ocular assessments
were successful and required no different
instructions for IC-8 IOL eyes
• Vitreoretinal surgery in eyes implanted with
the IC-8 IOL can be performed with ease and
good visibility2,3
1- Data courtesy of Dr. Amadeo Veloso
2- Results from a an animal study conducted by Dr. Barry Kupperman is Professor of Ophthalmology and Biomedical Engineering;
Chief, Retina Service; Vice-Chair, Clinical Research, Ophthalmology at UC Irvine School of Medicine
3-Personal experience in one patient form Professor Burkhardt Dick, MD
Fellow Eye
IC-8 IOL Eye
Images courtesy of Prof. Günther Grabner
10. Summary
– Reliably extends depth of focus
– Provides excellent visual acuity across all distances
– Is forgiving of refractive misses
– Tolerant to 1.50 D of astigmatism
– Has a low-level of visual symptoms
– Requires no surgical adaptation
– Is free of centration issues
– Allows posterior segment ocular assessments and
secondary procedures post implantation